Summary
Akashi Therapeutics Inc (Akashi Therapeutics), formerly DART Therapeutics Inc is a clinical stage biopharmaceutical company develops treatment for duchenne muscular dystrophy (DMD) and other rare pediatric diseases. The company provides pipeline portfolio such as HT-100, a small molecule drug candidate for the reduction of fibrosis and inflammation and to promote healthy muscle fiber regeneration in DMD patients; DT-200, an oral selective androgen receptor modulator (SARM) for the treat
Read More
- List of Tables
- Akashi Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
- Akashi Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
- Akashi Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
- Akashi Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
- Akashi Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
- Akashi Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 t
Read More
- Table of Contents
- Table of Contents 3
- List of Tables 4
- List of Figures 4
- Akashi Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
- Akashi Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
- Akashi Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
- Akashi Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
- Akashi Therapeutics Inc, Pharmaceuticals & Healthcare
Read More